CRISPR-mediated rapid arming of poxvirus vectors enables facile generation of the novel immunotherapeutic STINGPOX
Jack T. Whelan(University of Ottawa), John C. Bell(Ottawa Hospital)
Cited by 13
Related Papers
Use of a targeted oncolytic poxvirus, JX-594, in patients with refractory primary or metastatic liver cancer: a phase I trial
|The Lancet Oncology|2008|522
Reciprocal cellular cross-talk within the tumor microenvironment promotes oncolytic virus activity
|Nature Medicine|2015|167
Surgical Stress Promotes the Development of Cancer Metastases by a Coagulation-Dependent Mechanism Involving Natural Killer Cells in a Murine Model
|Annals of Surgery|2012|123
Combination of Paclitaxel and MG1 oncolytic virus as a successful strategy for breast cancer treatment
|Breast Cancer Research|2016|84